Fitness & Wellness Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Fitness & Wellness Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cytori Therapeutics
University of California Loses Rights to '231 Patent Licensed to Cytori; Ruling Unrelated to Celution System Family of Products
July 2nd, 2008
The University of California inventors were removed from U.S. patent number 6,777,231, which was licensed to Cytori Therapeutics (NASDAQ: CYTX). The decision was made today by the United States District Court in the Central District of California. The '231 patent covers isolated adipose-derived stem cells and does not affect Cytori's commercialization of the Celution(R) System or the Company's product pipeline. However, Cytori believes that the court's decision is incorrect and that the University of California may elect to appeal the ruling. Cytori was recently granted a foundational patent on its Celution(R) System device technology for processing...
Source: Fitness & Wellness Business Week (2008-07-02)
|
